Breaking News Instant updates and real-time market news.

AVMXY

Avita Medical

$0.00

(0.00%)

20:06
11/15/18
11/15
20:06
11/15/18
20:06

Avita Medical to hire U.S. sales team to support national launch of Recell

AVITA Medical announced that it has completed hiring of the U.S. sales team to support the U.S. market launch of the RECELL System for the treatment of acute thermal burns. The full direct sales team of 20 healthcare professionals has joined AVITA and are in the process of completing a rigorous training program, including on-site training within burn centers, in preparation for the market launch of the RECELL System. The Company also announced that in advance of the market launch a total of 32 U.S. burns centers are in active review of the RECELL System or have commenced ordering and are taking deliveries of the product. The U.S. sales team includes Regenerative Tissue Specialists who are based throughout the U.S. and will lead the qualification, account management, and relationship development within each burn center. Each RTS is highly experienced in the burn care market and well versed in the clinical aspects of patient care. Also incorporated in the sales team are Clinical Training Specialists who will train surgeons and nurses and assist burn centers in their use of the RECELL System. Each CTS is a Registered Nurse and joins AVITA with an accomplished background in burn care and institutional relationships. The efforts of the RTS and CTS teams to train and certify doctors and nurses will be augmented by AVITA's Medical Affairs team, a group that is highly experienced in the burn space and were responsible for training the 24 burn centers who participated in the clinical trials and Compassionate Use program for the RECELL System.

AVMXY Avita Medical
$0.00

(0.00%)

10/04/18
LSCM
10/04/18
INITIATION
Target $4
LSCM
Buy
Avita Medical assumed with a Buy at Lake Street
Lake Street analyst Brooks O'Neil assumed coverage of Avita Medical with a Buy rating and $4 price target. The company's Recell System, which received FDA approval on September 21 to treat severe thermal burns in patients 18 years and older, dramatically" improves patient outcomes, shortens length of stay, lowers treatment costs and improves productivity for doctors, O'Neil tells investors in a research note. The analyst believes this win/win/win/win solution" is the first meaningful innovation in burn care in more than 20 years.

TODAY'S FREE FLY STORIES

PREKF

PrairieSky Royalty

$0.00

(0.00%)

06:39
04/22/19
04/22
06:39
04/22/19
06:39
Conference/Events
PrairieSky Royalty management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

KRA

Kraton

$36.45

0.03 (0.08%)

06:35
04/22/19
04/22
06:35
04/22/19
06:35
Hot Stocks
Kraton appoints Atanas Atanasov as CFO »

Kraton announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

LLY

Eli Lilly

$115.20

-1.23 (-1.06%)

06:34
04/22/19
04/22
06:34
04/22/19
06:34
Hot Stocks
Eli Lilly announces licensing, research collaboration with Avidity »

Eli Lilly announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

NGD

New Gold

$0.86

-0.0141 (-1.61%)

06:34
04/22/19
04/22
06:34
04/22/19
06:34
Conference/Events
New Gold management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

UBER

Uber

$0.00

(0.00%)

, LYFT

Lyft

$58.31

-1.11 (-1.87%)

06:32
04/22/19
04/22
06:32
04/22/19
06:32
Periodicals
Uber, Lyft IPOs could cause higher fares, WSJ reports »

The initial public…

UBER

Uber

$0.00

(0.00%)

LYFT

Lyft

$58.31

-1.11 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ONB

Old National Bancorp

$16.85

-0.28 (-1.63%)

06:32
04/22/19
04/22
06:32
04/22/19
06:32
Earnings
Old National Bancorp reports Q1 adjusted EPS 33c, consensus 31c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 02

    May

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:30
04/22/19
04/22
06:30
04/22/19
06:30
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

CYAD

Celyad

$21.48

(0.00%)

06:29
04/22/19
04/22
06:29
04/22/19
06:29
Conference/Events
Celyad management to meet with »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

, BTC

Bitcoin

$0.00

(0.00%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Periodicals
JPMorgan to expand use of blockchain system to validate payments, FT says »

JPMorgan Chase plans to…

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 21

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:23
04/22/19
04/22
06:23
04/22/19
06:23
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$64.18

0.16 (0.25%)

, CVX

Chevron

$119.87

-0.38 (-0.32%)

06:20
04/22/19
04/22
06:20
04/22/19
06:20
Downgrade
Anadarko, Chevron rating change  »

Anadarko downgraded to…

APC

Anadarko

$64.18

0.16 (0.25%)

CVX

Chevron

$119.87

-0.38 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

  • 14

    May

  • 22

    May

RTRX

Retrophin

$20.07

-0.13 (-0.64%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Retrophin initiated  »

Retrophin initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 08

    May

  • 05

    Jun

  • 30

    Jun

MU

Micron

$43.42

0.26 (0.60%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Conference/Events
Micron management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRE

Watford Holdings

$28.24

0.5 (1.80%)

06:17
04/22/19
04/22
06:17
04/22/19
06:17
Initiation
Watford Holdings initiated  »

Watford Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$21.35

0.07 (0.33%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENGIY

Engie SA

$0.00

(0.00%)

, EME

Emcor

$79.55

2.64 (3.43%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Periodicals
France's Engie mulls takeover of Emcor, Bloomberg reports »

French energy firm Engie…

ENGIY

Engie SA

$0.00

(0.00%)

EME

Emcor

$79.55

2.64 (3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAL

Caleres

$27.55

0.425 (1.57%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOV

Dover

$97.93

1.12 (1.16%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Downgrade
Dover rating change  »

Dover downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

RCI

Rogers Communications

$51.39

-1.76 (-3.31%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Downgrade
Rogers Communications rating change  »

Rogers Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 23

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:10
04/22/19
04/22
06:10
04/22/19
06:10
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

CAL

Caleres

$27.55

0.425 (1.57%)

06:09
04/22/19
04/22
06:09
04/22/19
06:09
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBK

Triumph Bancorp

$29.38

-1.37 (-4.46%)

06:08
04/22/19
04/22
06:08
04/22/19
06:08
Downgrade
Triumph Bancorp rating change  »

Triumph Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.